Ultralife (NASDAQ:ULBI) Cut to “Buy” at StockNews.com

Ultralife (NASDAQ:ULBI) was downgraded by equities researchers at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Thursday.

Separately, Benchmark boosted their price target on Ultralife from $12.00 to $13.00 and gave the company a “buy” rating in a research report on Tuesday, March 5th.

Ultralife Stock Up 2.3 %

ULBI opened at $11.97 on Thursday. The business’s 50-day simple moving average is $9.36 and its 200-day simple moving average is $8.23. The company has a debt-to-equity ratio of 0.18, a quick ratio of 2.16 and a current ratio of 4.03. Ultralife has a one year low of $3.92 and a one year high of $12.22. The stock has a market capitalization of $197.15 million, a P/E ratio of 18.70 and a beta of 1.12.

Ultralife (NASDAQ:ULBI) last posted its earnings results on Thursday, February 15th. The technology company reported $0.18 EPS for the quarter. The business had revenue of $44.55 million for the quarter. Ultralife had a return on equity of 10.31% and a net margin of 6.19%.

Hedge Funds Weigh In On Ultralife

Several institutional investors have recently added to or reduced their stakes in the stock. Visionary Wealth Advisors increased its position in Ultralife by 0.9% in the 4th quarter. Visionary Wealth Advisors now owns 1,082,246 shares of the technology company’s stock valued at $7,381,000 after acquiring an additional 9,997 shares during the period. Janney Montgomery Scott LLC increased its position in Ultralife by 10.0% during the 1st quarter. Janney Montgomery Scott LLC now owns 439,100 shares of the technology company’s stock worth $3,868,000 after purchasing an additional 40,000 shares during the period. EAM Investors LLC acquired a new position in Ultralife during the 3rd quarter worth approximately $1,776,000. Acadian Asset Management LLC acquired a new position in Ultralife during the 3rd quarter worth approximately $1,039,000. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new position in Ultralife during the 3rd quarter worth approximately $641,000. Institutional investors and hedge funds own 30.68% of the company’s stock.

Ultralife Company Profile

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.